Additional information
| Active substance | Alfuzosin |
|---|---|
| Tab Piece | 30 Tabs |
| Side effects | Dizziness, headache, fatigue, orthostatic hypotension |
| Effects | Reduces symptoms of benign prostatic hyperplasia (BPH) |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically 10 mg once daily |
| Half-life | 10 hours |
| Main action | Relaxation of smooth muscles in the prostate and bladder neck |
| Substance class | Alpha-1 blocker |
| Formula | C19H27N5O4 |
| Chemical name | N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)methylamino]propyl]tetrahydro-2-furancarboxamide |
| Storage conditions | Store at room temperature away from moisture and heat |
| Reference | SPRM071 |
| ean13 | 1395574700708 |
| Dosage Unit | Tabs |
| FORM | Oral |
| Trade name | Uroxatral |
| Blood pressure | May cause a decrease in blood pressure |
| Also known as | Alfusozine, Xatral |
| Lab Test | Not specific |
| Hepatotoxicity | Low |
| Water Retention | Minimal |
| Dosage | 10 Mg |
| Use in sports | None |
| Packing | Blister |
Reviews
There are no reviews yet.